Explore Intra-Cellular Therapies' Q4 2024 financial performance, highlighting revenue growth, net losses, and strategic insights for investors. Key metrics and future outlook included.
Explore Talkspace, Inc.'s latest Form 8-K filed on February 20, 2025, detailing stock and warrants information vital for investors and analysts.
Explore Talkspace, Inc.'s 8-K filing from January 15, 2025, detailing major events, securities, and segment information for stakeholders.
Discover SciSparc Ltd.'s January 2025 Form 6-K report detailing a key partnership with Clearmind Medicine and a new European patent application in psychedelic therapy.
Explore LifeStance Health Group's 8-K report detailing significant corporate events as of December 19, 2024. Discover vital stock information and insights for investors.